Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodiesQizhen Shi|Journal of Clinical Investigation|2006Cited by 188
Immune tolerance induced by platelet‐targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediatedY. Chen, Qizhen Shi, Xiang Luo et al.|Journal of Thrombosis and Haemostasis|2017Cited by 34
The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunityYingyu Chen, Qizhen Shi, Jocelyn A. Schroeder et al.|Blood|2015Cited by 25
Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in miceChristina K. Baumgartner, Robert R. Montgomery, Jeremy G. Mattson et al.|Journal of Thrombosis and Haemostasis|2016Cited by 21
Platelet Gene Therapy Promotes Targeted Peripheral Tolerance by Clonal Deletion and Induction of Antigen-Specific Regulatory T CellsXiaofeng Luo, Qizhen Shi, Kenneth P. Allen et al.|Frontiers in Immunology|2018Cited by 15